US EditionEnzene Biosciences Cyberattack Leads To Fund Theft
Summary by The Cyber Express
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Enzene Biosciences Cyberattack Leads To Fund Theft
Alkem Laboratories Ltd has revealed that its wholly owned subsidiary, Enzene Biosciences, was the target of a cyberattack affecting its U.S. operations, which led to a fraudulent transfer of funds. The company disclosed the Enzene Biosciences cyberattack in a regulatory filing on Thursday, May 15, 2025. According to the statement submitted to the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), the Enzene Biosciences cyberatta…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
